Skip to main content
. 2017 Aug 3;8(47):81860–81872. doi: 10.18632/oncotarget.19899

Table 1. SPR summary of anti-TNF-α/IL-17A bsAb, anti-TNF-α mAb and anti-IL-17A mAb.

Antibody Antigen kon, (mol/L-1)s-1 koff, s-1 Rmax KD, mol/L
Anti-IL-17A mAb IL-17A 4.2×105 7.0×10-5 43.6 1.7×10-10
TNF-α No Binding
IL-17A+TNF-α 4.4×105 7.5×10-5 43.1 1.7×10-10
Anti-TNF-α mAb IL-17A No binding
TNF-α 4.7×105 1.7×10-4 57.8 3.7×10-10
IL-17A+TNF-α 4.7×105 1.7×10-4 60.3 3.7×10-10
BsAb IL-17A 4.0×105 7.9×10-5 30.6 2.0×10-10
TNF-α 4.7×105 1.6×10-4 59.1 3.3×10-10
IL-17A+TNF-α 4.6×105 1.2×10-4 88.6 2.5×10-10